Policy Issue Identification: Resolving Conflicts over Life- - - PowerPoint PPT Presentation
Policy Issue Identification: Resolving Conflicts over Life- - - PowerPoint PPT Presentation
Policy Issue Identification: Resolving Conflicts over Life- Sustaining Treatment in Virginia Dea Mahanes, MSN, RN, CCNS, FNCS NURS638 Health Policy, Leadership & Advocacy Virginia Commonwealth University Learning Objectives Understand
Learning Objectives
- Understand current Virginia law pertaining to
resolution of life-sustaining treatment conflicts.
- Analyze the impact of policy action or inaction from
the perspective of the patient, surrogate, and clinician.
- Apply Kingdon’s model to policy actions related to
life-sustaining treatment conflicts in Virginia.
Health Policy Issue Introduction
- Clinician-surrogate conflict over life-sustaining
treatment
- Life-sustaining treatment (LST), also referred
to as life-sustaining care: mechanical/artificial means to sustain, restore or replace a spontaneous vital function (paraphrased from the Va. Code Ann. §54.1-2990, 2009)
Health Policy Issue Introduction
- Overview of end-of-life care in the ICU
– 65% of deaths preceded by decision to withhold or withdraw LST (Lobo et al., 2017) – 33-38% of patients receive non-beneficial treatments (Cardona-Morrell et al., 2016)
- Disagreement about prognosis/treatment common
(Pope & Kemmerling, 2016)
– Common cause of moral distress (Whitehead, Herbertson, Hamric, Epstein, & Fisher, 2015; Hamric & Epstein, 2017)
Health Policy Issue Introduction
- Multi-society position statement: responding to
requests for inappropriate or potentially inappropriate treatment (Bosslet et al., 2015)
– Seven-step process to resolve conflicts
- SCCM policy statement: defining futile or potentially
inappropriate treatments (Kon et al., 2016)
– No reasonable expectation of improvement that would allow patient to survive outside of the acute care setting,
- r perceive the benefits of treatment
- “Clinicians should recognize the limits of prognostication…”
Health Policy Issue Introduction
- Code of Virginia, §54.1-2990 (2009)
– Clinicians are not obligated to provide treatment that is medically or ethically inappropriate – Care must be continued for a period of 14 days to enable the patient’s agent to seek transfer to another provider or facility – Does not address actions to be taken at the end of the 14-day period if no provider or facility has been located
Health Policy Issue Introduction
- Studied by Virginia Joint Commission on
Health Care in 2016 and 2017: Life-Sustaining Treatment Work Group (Mitchell, 2017)
– Survey of health systems in Virginia – Policy options:
- No action
- Introduce legislation to amend §54.1-2990 (drafted
language)
– Public comment period through October 12th
Health Policy Issue Introduction:
Draft Amendment (Mitchell, 2017)
- Allows for cessation of medically or ethically
inappropriate treatments after 14 days
– Special considerations for artificial hydration and nutrition
- Requires hospitals to enact policies that outline
actions to be taken in the event of treatment conflict
– Second medical opinion – Interdisciplinary medical review committee with
- pportunity for the patient/surrogate to participate
– Inclusion of decision (with explanation) in medical record
Health Policy Issue’s Relevance to Quality & Safety
- Population health
– Families as a vulnerable population
- Experience of care
– Communication – Transparency
- Cost
– Futile care cost estimate
- f $4004/day (Huynh et
al., 2013)
The Triple Aim Berwick, Nolan, & Whittington, 2008
Health Policy Issue’s Relevance to Quality & Safety
- Population health,
experience of care, cost plus…
- High quality health
care includes a focus
- n clinicians
– Meaning in work – Avoiding burnout
Population Health
Cost Clinician Health Experience
- f Care
The Quadruple Aim
Bodenheimer & Sinsky, 2014. Sikka, Morath, & Leape 2015.
Implication of Policy Action/Inaction
- Current Virginia statistics (Mitchell, 2017)
– 56% of health systems surveyed have a written process for managing intractable treatment conflict – 7 of 8 health systems without a written process believe a process is needed
- 5 of 7 identified lack of legislative clarity as a barrier
Implication of Policy Action:
Amendment Proposed and Passed
- Patients
– Protections against discrimination (Mitchell, 2017)
- Surrogate
– Clear process with opportunity for participation (Mitchell, 2017) – Potential relief at removal of decision-making pressures (Fine & Mayo, 2003)
- Clinicians
– Legislative protections if process followed (Mitchell, 2017) – Impact on moral distress
Implication of Policy Inaction:
State Statute Remains Unchanged
- Continue current practices
– Variability for patients, surrogates, and clinicians based on health system/organization
- Lack of clarity about actions to take after 14-day period
- Current Virginia statistics (Mitchell, 2017)
– 40 cases over 12 months in hospitals with a policy
- On average (by health system), 5% cases resulted in
withdrawal/withholding over objection
– Hospitals without a policy estimate 45-90 cases/yr
Theoretical Frame of Reference
Overview of the Kingdon Model (Kingdon, 1995)
- Information indicates the existence
- f a problem
Problem Stream
- Available solutions
Policy Stream
- Policy-makers/administration have
motive and opportunity to act
Political Stream
Window of Opportunity
Integrating Policy and Theory:
Kingdon and Treatment Conflict in Virginia
- Treatment conflict
- Common and impactful
- Lack of legislative clarity
Problem Stream
- National guidance documents
- Bosslet et al., 2015.
- Kon et al., 2016.
Policy Stream
- November Elections
- House of Delegates
- Executive Branch
Political Stream
Window of Opportunity
Learning Objectives
- Understand current Virginia law pertaining to
resolution of life-sustaining treatment conflicts.
- Analyze the impact of policy action or inaction from
the perspective of the patient, surrogate, and clinician.
- Apply Kingdon’s model to policy actions related to
life-sustaining treatment conflicts in Virginia.
References
- Berwick, D. M., Nolan, T. W., & Whittington, J. (2008). The triple aim: Care, health, and cost.
Health Affairs (Project Hope), 27(3), 759-769. doi:10.1377/hlthaff.27.3.759
- Bodenheimer, T., & Sinsky, C. (2014). From triple to quadruple aim: Care of the patient
requires care of the provider. Annals of Family Medicine, 12(6), 573-576. doi:10.1370/afm.1713
- Bosslet, G. T., Pope, T. M., Rubenfeld, G. D., Lo, B., Truog, R. D., Rushton, C. H., . . . Society of
Critical Care. (2015). An official ATS/AACN/ACCP/ESICM/SCCM policy statement: Responding to requests for potentially inappropriate treatments in intensive care units. American Journal
- f Respiratory and Critical Care Medicine, 191(11), 1318-1330. doi:10.1164/rccm.201505-
0924ST
- Cardona-Morrell, M., Kim, J., Turner, R. M., Anstey, M., Mitchell, I. A., & Hillman, K. (2016).
Non-beneficial treatments in hospital at the end of life: A systematic review on extent of the
- problem. International Journal for Quality in Health Care : Journal of the International Society
for Quality in Health Care, 28(4), 456-469. doi:10.1093/intqhc/mzw060
- Fine, R. L., & Mayo, T. W. (2003). Resolution of futility by due process: Early experience with
the Texas advance directives act. Annals of Internal Medicine, 138(9), 743-746. doi:200305060-00011
References
- Hamric, A. B., & Epstein, E. G. (2017). A health system-wide moral distress consultation
service: Development and evaluation. HEC Forum : An Interdisciplinary Journal on Hospitals' Ethical and Legal Issues, doi:10.1007/s10730-016-9315-y
- Huynh, T. N., Kleerup, E. C., Wiley, J. F., Savitsky, T. D., Guse, D., Garber, B. J., & Wenger, N. S.
(2013). The frequency and cost of treatment perceived to be futile in critical care. JAMA Internal Medicine, 173(20), 1887-1894. doi:10.1001/jamainternmed.2013.10261
- Kingdon, J. W. (1995). The policy window, and joining the streams. In Agendas, alternatives,
and public policies (2nd Ed., pp. 165-195). New York: Longman.
- Kon, A. A., Shepard, E. K., Sederstrom, N. O., Swoboda, S. M., Marshall, M. F., Birriel, B., &
Rincon, F. (2016). Defining futile and potentially inappropriate interventions: A policy statement from the society of critical care medicine ethics committee. Critical Care Medicine, 44(9), 1769-1774. doi:10.1097/CCM.0000000000001965
- Lobo, S. M., De Simoni, F. H. B., Jakob, S. M., Estella, A., Vadi, S., Bluethgen, A., . . . ICON
- investigators. (2017). Decision-making on withholding or withdrawing life support in the ICU:
A worldwide perspective. Chest, 152(2), 321-329. doi:S0012-3692(17)30820-6
References
- Mitchell, A. (September 19, 2017). Life-sustaining treatment guidelines work group – final
report to the Joint Commission on Health Care. Retrieved from http://jchc.virginia.gov/2.%20Life%20Sustaining%20Treatment%20Guidelines%20- %20final%20report%20-%20revised%20-%209.20.17.pdf
- Pope, T. M., & Kemmerling, K. (2016). Legal briefing: Stopping nonbeneficial life-sustaining
treatment without consent. The Journal of Clinical Ethics, 27(3), 254-264. doi:2016273254
- Sikka, R., Morath, J. M., & Leape, L. (2015). The quadruple aim: Care, health, cost and
meaning in work. BMJ Quality & Safety, 24(10), 608-610. doi:10.1136/bmjqs-2015-004160
- Va. Code Ann. §54.1-2990, 2009, Retrieved from
https://law.lis.virginia.gov/vacode/title54.1/chapter29/section54.1-2990/
- Whitehead, P. B., Herbertson, R. K., Hamric, A. B., Epstein, E. G., & Fisher, J. M. (2015). Moral
distress among healthcare professionals: Report of an institution-wide survey. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society
- f Nursing / Sigma Theta Tau, 47(2), 117-125. doi:10.1111/jnu.12115